about
Dengue Virus Immunopathogenesis: Lessons Applicable to the Emergence of Zika VirusSimplified process for the production of anti-CD19-CAR-engineered T cellsDifferential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cellsQuality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling.Monocyte-derived DC maturation strategies and related pathways: a transcriptional view15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level.Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments.Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment.Social threat exposure in juvenile mice promotes cocaine-seeking by altering blood clotting and brain vasculature.15 kDa granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity.Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescenceLeukemia cells induce changes in human bone marrow stromal cells.Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways.Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting.Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis.Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients.Clinical Applications of Activated Immune CellsSIRT1 Modulates the Sensitivity of Prostate Cancer Cells to Vesicular Stomatitis Virus OncolysisClinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial
P50
Q27010600-C464B881-9CE7-4486-AD17-25F1B70B7277Q34078460-784C6330-869B-4698-AE75-E85B8848031DQ34103945-BC4FB231-B2A3-4D8F-B3C2-680248F05D26Q34311362-A155C978-93D3-4173-B4D5-80C15E2B9476Q34916497-29BC8D0F-E492-48D2-878C-A3E40C5F2911Q34980279-3E45B35F-E219-46A5-9B0B-34D5C176E6C1Q35047686-A62DE74F-D6E7-4000-9309-3236C79ADD0EQ35627237-79D43A37-BEC7-472F-B624-A3C7C4849722Q35706934-02BF8580-FE91-4225-9090-CA7B2EDB649DQ35921861-34179BF8-A7F0-4C72-B693-8384EB81D843Q36016677-DC3F3B4E-24A8-43FE-9CA0-FA11B8DE05C0Q36761521-5AA3DF79-A2B7-4F06-B20C-09E70FEB5A0FQ37224581-B610F0A4-E375-4D00-BA8C-F0189AE912F3Q37281919-D9E22363-3FC4-44E8-A878-A7D469D9178DQ37441710-67FF4A91-4263-402E-8EBA-E03DB1A31BCBQ45284571-6C327569-BD0A-474B-96D6-D22A1FF01AD8Q46507832-0EB62DD5-742C-4760-8114-6BFA0789AF7CQ49248446-D7FD37A6-C48E-44AA-B1BA-1E576D786CE9Q51201669-4B2D1E7F-5B2E-49BB-9E35-DEAA2C91EDDDQ56767684-85BCCF58-9521-4CA7-A552-C7832210F481Q92049715-8BACBBDF-E0DE-4D51-BA7C-D69E033C971AQ92570753-9719A0DE-99E0-4518-974E-0145624F7F47
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Luciano Castiello
@ast
Luciano Castiello
@en
Luciano Castiello
@es
Luciano Castiello
@nl
Luciano Castiello
@sl
type
label
Luciano Castiello
@ast
Luciano Castiello
@en
Luciano Castiello
@es
Luciano Castiello
@nl
Luciano Castiello
@sl
prefLabel
Luciano Castiello
@ast
Luciano Castiello
@en
Luciano Castiello
@es
Luciano Castiello
@nl
Luciano Castiello
@sl
P1053
K-8616-2016
P106
P1153
37076666400
P21
P31
P3829
P496
0000-0001-7146-3158